Market Research Logo

Rontis AG - Product Pipeline Analysis, 2016 Update


Rontis AG (Rontis), a subsidiary of Rontis Corporation S.A., is a specialty healthcare company with a focus on medical devices, pharmaceuticals, infant and baby nutrition, dermaceuticals and healthcare services. The company offers various medical devices including interventional cardiology and radiology products, disposables, and back-pain products. It also specializes in producing a range of solid dose formulations. Rontis offers disposables for nephrology, urology, liquid administration and anesthesiology. The company produces infant and baby nutrition and dermaceutical products. Its healthcare services include hemodialysis and dialysis. The company operates manufacturing, dialysis centers, research and development; production and packaging centers. Rontis is headquartered in Zug, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Rontis AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Rontis AG Company Snapshot
Rontis AG Company Overview
Key Information
Rontis AG Pipeline Products and Clinical Trials Overview
Rontis AG - Major Products and Services
Rontis AG Pipeline Products by Development Stage
Rontis AG Pipeline Products Overview
Bifurcation Stent System
Bifurcation Stent System Product Overview
CRONUS PTNA Dilatation Catheter
CRONUS PTNA Dilatation Catheter Product Overview
Drug Eluting Dilatation Catheter
Drug Eluting Dilatation Catheter Product Overview
Peripheral Guidewire - 0.035
Peripheral Guidewire - 0.035 Product Overview
Rontis AG - Key Competitors
Rontis AG - Key Employees
Rontis AG - Locations And Subsidiaries
Head Office
Recent Developments
Rontis AG, Recent Developments
Jul 10, 2012: Rontis Announces Patient Enrollment In eazy Registry To Evaluate Safety And Performance Of Zeus CC
Jun 15, 2012: Rontis Receives CE Mark Approval For Abrax Sirolimus-Eluting Biodegradable Polymer Stent System
May 23, 2012: Tryton Announces Positive Clinical Data From Patients Treated With Bifurcation Stent System At EuroPCR 2012
May 15, 2011: Rontis Launches Triton BTK Balloon Dilatation Catheter
May 10, 2011: Rontis Launches Zeus SX Self-Expandable Stent System For Peripheral Applications
About GlobalData
Contact Us
List of Tables
Rontis AG, Key Facts
Rontis AG Pipeline Products and Clinical Trials Overview
Rontis AG Pipeline Products by Equipment Type
Rontis AG Pipeline Products by Indication
Rontis AG, Major Products and Services
Rontis AG Number of Pipeline Products by Development Stage
Rontis AG Pipeline Products Summary by Development Stage
Bifurcation Stent System - Product Status
Bifurcation Stent System - Product Description
CRONUS PTNA Dilatation Catheter - Product Status
CRONUS PTNA Dilatation Catheter - Product Description
Drug Eluting Dilatation Catheter - Product Status
Drug Eluting Dilatation Catheter - Product Description
Peripheral Guidewire - 0.035 - Product Status
Peripheral Guidewire - 0.035 - Product Description
Rontis AG, Key Employees
List of Figures
Rontis AG Pipeline Products by Equipment Type
Rontis AG Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report